Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 37 citing articles:

The Dual Role of Autophagy in Cancer Development and a Therapeutic Strategy for Cancer by Targeting Autophagy
Chul Won Yun, Juhee Jeon, Gyeongyun Go, et al.
International Journal of Molecular Sciences (2020) Vol. 22, Iss. 1, pp. 179-179
Open Access | Times Cited: 132
Mitochondrial quality surveillance as a therapeutic target in myocardial infarction
Hang Zhu, Sam Toan, David Mui, et al.
Acta Physiologica (2020) Vol. 231, Iss. 3
Closed Access | Times Cited: 125
RBR E3 ubiquitin ligases in tumorigenesis
Peter Wang, Xiaoming Dai, Wenxiao Jiang, et al.
Seminars in Cancer Biology (2020) Vol. 67, pp. 131-144
Closed Access | Times Cited: 80
The Anticancer Properties of Tanshinones and the Pharmacological Effects of Their Active Ingredients
Li Fu, Bing Han, Yang Zhou, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 73
Tanshinone IIA combined with cisplatin synergistically inhibits non‐small‐cell lung cancer in vitro and in vivo via down‐regulating the phosphatidylinositol 3‐kinase/Akt signalling pathway
Xiaozhong Liao, Ying Gao, Sheng Huang, et al.
Phytotherapy Research (2019) Vol. 33, Iss. 9, pp. 2298-2309
Open Access | Times Cited: 55
Advances on Natural Abietane, Labdane and Clerodane Diterpenes as Anti-Cancer Agents: Sources and Mechanisms of Action
Rosaria Acquaviva, Giuseppe Antonio Malfa, Monica Rosa Loizzo, et al.
Molecules (2022) Vol. 27, Iss. 15, pp. 4791-4791
Open Access | Times Cited: 32
Pharmacological basis of tanshinone and new insights into tanshinone as a multitarget natural product for multifaceted diseases
Zhibei Li, Jing Zou, Dan Cao, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 130, pp. 110599-110599
Open Access | Times Cited: 45
Mitochondria autophagy: a potential target for cancer therapy
Yuhan Qiu, Tianshu Zhang, Xiaowei Wang, et al.
Journal of drug targeting (2021) Vol. 29, Iss. 6, pp. 576-591
Closed Access | Times Cited: 36
Recent Research Progress (2015–2021) and Perspectives on the Pharmacological Effects and Mechanisms of Tanshinone IIA
Chenhui Zhong, Zuan Lin, Liyuan Ke, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 33
Mitophagy: A crucial modulator in the pathogenesis of chronic diseases
Xiao Yang, Weinan Pan, Gaosheng Xu, et al.
Clinica Chimica Acta (2019) Vol. 502, pp. 245-254
Closed Access | Times Cited: 41
Alantolactone induces apoptosis through ROS-mediated AKT pathway and inhibition of PINK1-mediated mitophagy in human HepG2 cells
Xing Kang, Hijuan Wang, Yanwei Li, et al.
Artificial Cells Nanomedicine and Biotechnology (2019) Vol. 47, Iss. 1, pp. 1961-1970
Open Access | Times Cited: 40
Tanshinone IIA reduces SW837 colorectal cancer cell viability via the promotion of mitochondrial fission by activating JNK-Mff signaling pathways
Sayilaxi Jieensinue, Hong Zhu, Guangcheng Li, et al.
BMC Cell Biology (2018) Vol. 19, Iss. 1
Open Access | Times Cited: 39
Tanshinone IIA suppresses ovarian cancer growth through inhibiting malignant properties and angiogenesis
Jin Zhou, Yuanyuan Jiang, Xiaoxia Wang, et al.
Annals of Translational Medicine (2020) Vol. 8, Iss. 20, pp. 1295-1295
Open Access | Times Cited: 30
Tanshinone IIA: Pharmacology, Total Synthesis, and Progress in Structure-modifications
Xing Huang, Hao Deng, Qing‐Kun Shen, et al.
Current Medicinal Chemistry (2021) Vol. 29, Iss. 11, pp. 1959-1989
Closed Access | Times Cited: 24
Mitochondrial Control in Inflammatory Gastrointestinal Diseases
Guo-Yan Sui, Feng Wang, Jin Lee, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14890-14890
Open Access | Times Cited: 16
Tanshinone IIA targeting cell signaling pathways: a plausible paradigm for cancer therapy
Syed Sahajada Mahafujul Alam, Arijit Samanta, Faizan Uddin, et al.
Pharmacological Reports (2023) Vol. 75, Iss. 4, pp. 907-922
Closed Access | Times Cited: 10
Silibinin-induced mitochondria fission leads to mitophagy, which attenuates silibinin-induced apoptosis in MCF-7 and MDA-MB-231 cells
Lingling Si, Jianing Fu, Weiwei Liu, et al.
Archives of Biochemistry and Biophysics (2020) Vol. 685, pp. 108284-108284
Closed Access | Times Cited: 26
Mitophagy in Diabetic Kidney Disease
Xiaofeng Zhang, Jing Feng, Xia Li, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 18
A mitophagy-related gene signature associated with prognosis and immune microenvironment in colorectal cancer
Cong Zhang, Cailing Zeng, Shaoquan Xiong, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 12
Identifying prognostic biomarkers in oral squamous cell carcinoma: an integrated single-cell and bulk RNA sequencing study on mitophagy-related genes
Minsi Li, Yi Wei, Wenhua Huang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Abiraterone and MDV3100 inhibits the proliferation and promotes the apoptosis of prostate cancer cells through mitophagy
Jingli Han, Junhua Zhang, Yaoguang Zhang, et al.
Cancer Cell International (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 17
Tanshinone IIA reverses EGF‑ and TGF‑β1‑mediated epithelial‑mesenchymal transition in HepG2 cells via the PI3K/Akt/ERK signaling pathway
Longkai Zhang, Weibin Lin, Xiaodan Chen, et al.
Oncology Letters (2019)
Open Access | Times Cited: 16
Mitochondrion-Directed Nanoparticles Loaded with a Natural Compound and a microRNA for Promoting Cancer Cell Death via the Modulation of Tumor Metabolism and Mitochondrial Dynamics
Yu‐Li Lo, Chen-Shen Wang, Yen‐Chun Chen, et al.
Pharmaceutics (2020) Vol. 12, Iss. 8, pp. 756-756
Open Access | Times Cited: 16
Tanshinone IIA inhibits endometrial carcinoma growth through the MAPK/ERK/TRIB3 pathway
Wenwen Zhang, Meihua Liu, Yurou Ji, et al.
Archives of Biochemistry and Biophysics (2023) Vol. 743, pp. 109655-109655
Open Access | Times Cited: 5
An overview of the anti-cancer actions of Tanshinones, derived from Salvia miltiorrhiza (Danshen)
Irum Naz, Myriam Mérarchi, Shanaya Ramchandani, et al.
Exploration of Targeted Anti-tumor Therapy (2020) Vol. 1, Iss. 3
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top